Clinical Trials Logo

Abdominal Pain clinical trials

View clinical trials related to Abdominal Pain.

Filter by:

NCT ID: NCT01562483 Completed - Chronic Pain Clinical Trials

The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain

Start date: October 2012
Phase: Phase 2
Study type: Interventional

Persistent postsurgical abdominal pain (PPAP) is a very difficult to treat pain. This pain can persist for months or even years and significantly diminishes quality of life. The exact underlying cause for this pain persistence is still unclear, which makes its treatment still a challenge. The promising analgesic effects of Δ9-THC in previous research, plus the improved bioavailability of Namisol® in comparison with previous Δ9-THC substances form the basis of the present research proposal. The current study aims to investigate the analgesic efficacy of Namisol® as add-on analgesic during a long-term treatment (52 days) of persistent postsurgical abdominal pain.

NCT ID: NCT01551511 Completed - Chronic Pain Clinical Trials

Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain

Start date: October 2012
Phase: Phase 2
Study type: Interventional

Abdominal pain resulting from chronic pancreatitis (CP) is often recurrent, intense and long-lasting, and is extremely difficult to treat. Medical analgesic therapy is considered as first choice in pain management of CP, resulting in regularly prescription of opioids. The adverse consequences of prolonged opioid use, including addiction, tolerance and opioid induced hyperalgesia, call for an alternative medical treatment. Cannabis has been used to treat pain for many centuries. Delta-9-tetrahydrocannabinol (Δ9-THC), the psychoactive substance of the cannabis plant, has been shown in previous studies to be a promising analgesic. The development of Namisol®, a tablet containing purified Δ9-THC showing an improved pharmacokinetic profile, provides the opportunity to test the analgesic potential of Δ9-THC in favourable conditions. The current study aims to investigate the analgesic efficacy of Namisol® as add-on analgesic during a long-term treatment (52 days) of abdominal pain resulting from CP.

NCT ID: NCT01531218 Completed - Diarrhea Clinical Trials

Trial Of Azithromycin In Campylobacter Concisus Patients With Diarrhea

Concisus2012
Start date: March 2012
Phase: Phase 3
Study type: Interventional

A randomized, double-blind, placebo-controlled clinical trial of azithromycin in Campylobacter concisus culture positive patients with diarrhea. The clinical characteristics of emerging Campylobacter concisus in adults is vomiting and persistent diarrhea. Whether patients may benefit from antibiotic treatment is unknown. The purpose of this trial is to investigate whether antibiotic treatment with azithromycin of Campylobacter concisus induced diarrhea can better the symptoms and shorten the duration of illness.

NCT ID: NCT01496378 Completed - Chronic Pain Clinical Trials

Problem Solving Skills Training For Parent Caregivers of Youth With Chronic Pain

Start date: May 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the feasibility and efficacy of problem-solving skills training (PSST) to reduce distress and increase coping abilities among parents of youth with chronic pain. We hypothesize that parents will complete the PSST intervention and will find it to be an acceptable and satisfactory treatment. We also hypothesize that parents who receive PSST will have less distress and better coping skills than parents who receive standard care, and that children of parents who receive PSST will have better physical and emotional functioning than children of parents who receive standard care.

NCT ID: NCT01495806 Completed - Clinical trials for Functional Gastrointestinal Disorders

Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood

Start date: January 2010
Phase: Phase 4
Study type: Interventional

Background: Functional abdominal pain disorders (FAPD) are common in school-aged children; however, there is no reliable treatment. Aim: To determine the efficacy and safety of glucomannan for treating FAPD in children. Trial Setting: Department of Pediatrics, The Medical University of Warsaw. Intervention: Patients will be enrolled in a double-blind, randomized controlled trial in which they will receive either glucomannan (10g) or placebo for 4 weeks.

NCT ID: NCT01450202 Completed - Pain Clinical Trials

Safety and Efficacy of Carbon Dioxide Insufflation During Colonoscopy With Consecutive Esophagogastroduodenoscopy in Reduction of Abdominal Pain in Sedated Outpatients

COCE
Start date: November 2011
Phase: Phase 3
Study type: Interventional

Compared with performing each procedure individually, performing two combined procedures such as colonoscopy consecutive Esophagogastroduodenoscopy (EGD) cause more bowel gases, abdominal distension and post-procedure pain because of longer procedure time related to more bowel insufflated gas than one procedure. To the best of the investigators knowledge, there has been no randomized controlled trial of CO2 versus air for insufflations during combined two procedures, colonoscopy with consecutive EGD. And there are a few well randomized trials concerned CO2 insufflation in patients receiving sedation during colonoscopy. The aim of the present study was to evaluate the efficacy of CO2 in reducing post-procedural abdominal pain and distension during colonoscopy consecutive EGD and to confirm the safety of CO2 insufflation when it is used during procedure in sedated outpatients.

NCT ID: NCT01408264 Completed - Abdominal Pain Clinical Trials

A Trial of 0.025 Wire Guided Cannulation Versus Current Practice 0.035 Wire Guided Cannulation

Start date: August 2010
Phase: Phase 4
Study type: Interventional

The aim of this study is to determine whether using a smaller wire results in a higher success rate at endoscopic retrograde cholangiopancreatography (ERCP), and lower incidence of adverse events

NCT ID: NCT01376414 Completed - Peptic Ulcer Clinical Trials

H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department

Start date: March 2011
Phase: N/A
Study type: Observational

This pilot study aims to estimate the prevalence of Helicobacter pylori (H. pylori) colonization in patients presenting with non-specific abdominal pain (NSAP) in an urban academic emergency department (ED) located in Washington, DC.

NCT ID: NCT01339117 Completed - Clinical trials for Irritable Bowel Syndrome

Delivered Dietary Intervention for Children With Irritable Bowel Syndrome

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a specific diet may help children with irritable bowel syndrome.

NCT ID: NCT01318369 Completed - Abdominal Pain Clinical Trials

Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain

Delta-pain
Start date: October 2011
Phase: Phase 2
Study type: Interventional

The main goal of this trial is to study the efficacy of Namisol® after a single dose of Δ9-THC in the treatment of pain resulting from chronic pancreatitis. Objective measures of pain processing, e.g. encephalography (EEG) and quantitative sensory testing (QST), are included to provide insight in underlying nociceptive processing.